Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099]
- BOND RX™ Validated
- Recombinant
- Advanced Validation
- RabMAb
- 20ul selling size
- What is this?
5
(4 Reviews)
|
(125 Publications)
Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (ab92336) is a rabbit monoclonal antibody detecting RUNX1 / AML1 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, IHC-P, IHC-Fr. Suitable for Human, Mouse, Rat.
- Biophysical QC for unrivalled batch-batch consistency
- Over 80 publications
- Trusted since 2010
View Alternative Names
AML1, CBFA2, RUNX1, Runt-related transcription factor 1, Acute myeloid leukemia 1 protein, Core-binding factor subunit alpha-2, Oncogene AML-1, Polyomavirus enhancer-binding protein 2 alpha B subunit, SL3-3 enhancer factor 1 alpha B subunit, SL3/AKV core-binding factor alpha B subunit, CBF-alpha-2, PEA2-alpha B, PEBP2-alpha B
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (AB92336)
Immunohistochemistry staining of RUNX1 / AML1 in formalin-fixed, paraffin-embedded Human tonsil tissue using 1/100 ab92336. Heat mediated antigen retrieval was performed via the pressure cooker method before commencing with IHC staining protocol.
- IHC-Fr
Lab
Immunohistochemistry (Frozen sections) - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (AB92336)
IHC image of RUNX1 / AML1 + RUNX3 + RUNX2 staining in a section of frozen normal human tonsil performed on a Leica BONDTM system using the standard protocol. The section was fixed in 10% paraformaldehyde (10 min) prior to staining. The section was incubated with ab92336, 1/500 dilution, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (AB92336)
Intracellular flow cytometric analysis of permeabilized Molt-4 cells using anti-RUNX1 ab92336 (red) or a rabbit IgG (negative) (green).
- IP
Lab
Immunoprecipitation - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (AB92336)
ab92336 (purified) at 1/20 immunoprecipitating RUNX1 / AML1 + RUNX3 + RUNX2 in 10 μg Molt-4 (Human lymphoblastic leukemia T lymphoblast)whole cell lysate (Lanes 1 and 2, observed at 49 kDa). Lane 3 - Rabbit monoclonal IgG (ab172730) instead of ab92336 in Molt-4 whole cell lysate. For western blotting, ab92336 at 1/500 and VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Blocking/Dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (ab92336)
false
- WB
Lab
Western blot - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (AB92336)
Blocking and diluting buffer : 5% NFDM/TBST
Exposure time : 10 seconds and 100 seconds
All lanes:
Western blot - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (ab92336) at 1/1000 dilution
Lane 1:
Myc-DDK-tagged Human RUNX1 recombinant protein at 20 ng
Lane 2:
His-tagged Human RUNX2 recombinant protein at 20 ng
Lane 3:
His-tagged Human RUNX3 recombinant protein at 20 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 48.7 kDa
Observed band size: 48 kDa,55 kDa
false
- WB
Unknown
Western blot - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (AB92336)
All lanes:
Western blot - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (ab92336) at 1/10000 dilution
Lane 1:
MOLT4 cell lysate at 10 µg
Lane 2:
fetal thymus lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
false
- WB
Lab
Western blot - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (AB92336)
Blocking/Diluting buffer and concentration : 5% NFDM /TBST
All lanes:
Western blot - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (ab92336) at 1.28 µg/mL
Lane 1:
Raw264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 2:
Molt-4 (Human lymphoblastic leukemia T lymphoblast) whole cell lysate at 20 µg
Lane 3:
WEHI-3 (Mouse leukemia lymphoblast) whole cell lysate at 20 µg
Lane 4:
Mouse thymus lysate at 20 µg
Lane 5:
CTLL-2 (Mouse T lymphocyte) whole cell lysate at 20 µg
Lane 6:
Rat thymus lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 0.05 µg/mL
false
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (AB92336)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 K-562 (Human chronic myelogenous leukemia lymphoblast) cells and 5µg of ab92336 [EPR3099]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Lab
Western blot - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (AB92336)
Blocking/Diluting buffer and concentration : 5% NFDM /TBST
All lanes:
Western blot - Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (ab92336) at 1.28 µg/mL
Lane 1:
Mouse spleen lysate at 20 µg
Lane 2:
Mouse thymus lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 0.05 µg/mL
false
Related conjugates and formulations (10)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-RUNX1 / AML1+RUNX3+RUNX2 antibody [EPR3099]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-RUNX1 / AML1+RUNX3+RUNX2 antibody [EPR3099]
-
Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] - BSA and Azide free
-
578 PE
PE Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099]
-
660 APC
APC Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099]
-
HRP Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099]
Reactivity data
Product details
What is this antibody validated in?
Anti-RUNX1 / AML1 + RUNX3 + RUNX2 antibody [EPR3099] (ab92336) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr) in Human, Mouse, Rat samples.
What is the molecular weight of RUNX1 / AML1?
Anti-RUNX1 / AML1 + RUNX3 + RUNX2 [EPR3099] (ab92336) specifically detects a band for RUNX1 / AML1 (UniProt: Q01196) at a molecular weight of 49kDa.
Trusted by the scientific community
Anti-RUNX1 / AML1 + RUNX3 + RUNX2 [EPR3099] (ab92336) was first used in a scientific publication in 2010 and has been cited over 80 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR3099] also available for your convenience: ab92336, Alexa Fluor® 488 - ab199221, Alexa Fluor® 647 - ab199493, Alexa Fluor® 555 - ab207253, Carrier free - ab220117, PE - ab305695, APC - ab305696, HRP - ab305697, Alkaline Phosphatase - ab308858, Alexa Fluor® 568 - ab312598, Alexa Fluor® 750 - ab321748
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RUNX1 RUNX2 and RUNX3 control processes in development and differentiation. They often function as part of a transcriptional complex with CBFΒ enhancing DNA binding and transcriptional activity. RUNX1 is vital in hematopoiesis guiding the formation of blood cells. RUNX2 predominantly influences bone development by regulating osteoblast differentiation while RUNX3 impacts neural development and T-cell maturation. These proteins collectively integrate signals to ensure proper cell lineage decisions.
Pathways
RUNX proteins participate in essential cellular pathways like the Wnt and TGF-Β signaling pathways. The Wnt pathway involves interaction with Β-catenin affecting cell fate and development processes. RUNX2 plays a significant role here by contributing to bone formation. The TGF-Β pathway influences cell growth and differentiation by interacting with SMAD proteins primarily through RUNX3 which modulates immune responses and tumorigenesis. These pathways highlight RUNX proteins' critical integration in signaling networks.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download chicCutRunSequencingBooklet|en
Target data
Additional targets
Publications (125)
Recent publications for all applications. Explore the full list and refine your search
Cellular and molecular life sciences : CMLS 82:351 PubMed41055656
2025
Applications
Unspecified application
Species
Unspecified reactive species
eLife 14: PubMed40637239
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 23:348 PubMed40369573
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:112398 PubMed40322079
2025
Applications
Unspecified application
Species
Unspecified reactive species
PLoS biology 23:e3003003 PubMed39874373
2025
Applications
Unspecified application
Species
Unspecified reactive species
eLife 13: PubMed39714446
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 15:455 PubMed39609719
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of applied oral science : revista FOB 32:e20240268 PubMed39476105
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules & biomedicine 25:472-481 PubMed39151099
2024
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 14:4256-4277 PubMed39113793
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com